The first installation of Finesse’s new SmartFactory platform was featured when Alvotech announced the opening of its state-of-the-art manufacturing and lab facility in Reykjavik, Iceland. Alvotech, Iceland’s powerful new player in biopharmaceuticals, will use this hybrid facility to rapidly expand its production capacity using multiple 1,000 L and 2,000 L single-use bioreactor trains. The facility, located at the University of Iceland Science Park, will leverage cutting-edge automation, enabling Alvotech to produce higher yields, significantly reduce labor and capital expenses, and…